Global DNA Sequencing Products Market Report and Forecast 2024-2032

Global DNA Sequencing Products Market Outlook

The global market value was USD 6.41 billion in 2023, driven by the increasing advancements in sequencing technologies across the globe. The market size is anticipated to grow at a CAGR of 16% during the forecast period of 2024-2032 to achieve a value of USD 24.40 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Researchers and developers have developed a variety of DNA sequencing technologies that provide higher precision and faster sequencing at a reduced cost. For example, Illumina, a key player, has introduced a device consisting of 10 ultra-throughput sequencers and can sequence approximately 18,000 human genomes per year. Researchers now use ground-breaking genome mapping techniques that take less time to complete. Thus, the reduction of sequencing costs has led many organisations to invest in research and development programs, providing economical approaches such as genome sequencing as a whole, novo sequencing, and the detection of particular diseases. These factors are expected to propel the growth of the DNA sequencing products market in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

DNA sequencing is the method used to measure sequences correctly in a DNA molecule, i.e. cytosine, adenine, thymine, and guanine, of the four nuclear bases. It plays a significant role in the mapping of the human genome and helps in multiple applications of scientific science. The products, thus, are gaining popularity in the pharmaceutical industry by helping researchers understand complex diseases and, in effect, by creating customised patient medicines. DNA profiling has, furthermore, become an essential part of forensic science, since these profiles enable researchers to recognise and differentiate multiple samples from a DNA pool.

On the basis of product type, the industry can be divided into the following:

• Consumables and ReagentsEquipment

It finds wide applications in the following:

• Biomarkers
• Diagnostics
• Reproductive Health
• Forensics
• Personalised Medicine
• Others

The end-use sectors in the market are:

• Academic and Government Research Institutes 
• Pharmaceutical and Biotechnology Companies 
• Hospitals and Clinics
• Others

The regional markets for the products include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Microorganism genome mapping and sequencing have made it possible for farmers to use them for crops and food plants. Over the last few years, in food plants, different bacterial genes have been used to enhance their resistance to insects and pests, which has improved their production and nutritional value. Genomes from many domesticated animals, including chicken, pig, cow, sheep, and horses, were sequenced, partially or entirely, and were also shown to be useful for the development of animals with improved meat and milk quality. The role of DNA sequencing in the in-vitro diagnostics industry is expected to gain momentum, especially for point-of-care diagnostics. DNA sequencing allows the development of accurate medicine to provide patients with unique medications or therapies. This also offers numerous tools for genetic sequencing and study of DNA data with high precision and rapid diagnosis at the point of treatment. Thus, the growing adoption of the products across agricultural and medical sectors is expected to support the growth of the global DNA sequencing products market.

Competitive Landscape

The report gives a detailed analysis of the following companies in the global DNA sequencing products market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Illumina Inc.
• Thermo Fischer Scientific Inc.
• Oxford Nanopore Technologies plc.
• Agilent Technologies, Inc.
• BGI
• PerkinElmer Inc.
• QIAGEN
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Takara Bio Inc.
• GENEWIZ, Inc.
• Hamilton Company
• Macrogen Inc.
• Zymo Research Corporation

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report